Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrofurantoin for overactive bladder patients with pyuria and negative culture (with and without multiple sclerosis)
2009-017939-18Phase 4Terminated
- Sponsor
- University College London
- Start
- Aug 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nitrofurantoin in overactive bladder (OAB) and urinary tract infection (UTI), sponsored by University College London. Primary endpoint: Change in average voided volume. Started Aug 2010; status: terminated.
02
Drugs
nitrofurantoin
03
Conditions
overactive bladder (OAB)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2009-017939-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017939-18.